Bevacizumab Versus Docetaxel/Erlotinib on Tumor Metrics in Patients With Previously Untreated Advanced Non Small Cell Lung Cancer
Clinical trial NCT04257864 · COMPLETED
Trial details
- NCT number
- NCT04257864
- Sponsor
- Hellenic Cooperative Oncology Group
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-05-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.